⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Lonafarnib (Farnesyltransferase Inhibition)
Current understanding
To be populated as evidence accumulates.
Evidence log
Open questions
Related
Contributing findings
Biomarkers and therapies associated with Hutchinson-Gilford Progeria Syndrome.
17-jun-2026
novelty 2
per-area 3
strengthens